How AI Is Modernizing Clinical Trial Protocols for Smarter Drug Development
By
Laura Russell
A five-star bake. Worth schmearing, sharing, saving.
Summary
This article examines how artificial intelligence is being applied to modernize clinical trial protocols, which have remained largely static and document-based despite advances in drug discovery. It highlights the inefficiencies of traditional fixed protocols—citing that 76% of trials fail to meet enrollment targets—and explores how AI, machine learning, and data science can analyze historical clinical operations data (performance, feasibility, enrollment patterns, resource utilization) to generate structured intelligence for smarter, adaptive trial designs.
Key quotes
· 3 pulledAccording to the Tufts Center for the Study of Drug Development (CSDD), 76% of trials fail to meet enrollment targets.
Data science, machine learning, and artificial intelligence (AI) have advanced quickly, but trial execution remains anchored to static documents that don't capture lessons from past studies or adapt to operational realities.
By fine-tuning domain-specific models with real clinical operations data — such as historical performance, feasibility outcomes, enrollment patterns, and resource utilization — hidden information can be translated into structured intelligence.
You might also wanna read
FDA's AI for Drug Approvals Found to Fabricate Studies
The FDA's AI system, designed to expedite drug approvals, has been discovered to generate fake studies and misrepresent research, raising co
The Onion·10mo ago
AI Advances in Drug Discovery: From Data Integration to Dual-Action Cancer Drug Design
The article discusses recent advancements in AI-driven drug discovery, highlighting two key developments: 1) Analytica 2026, an event focuse
drugtargetreview.com·4mo ago
Evaluating AI Agent Performance: Challenges Beyond Traditional Metrics
The article discusses the growing adoption of AI agents in real-world applications and the challenges in evaluating their performance. It ex
research.google·4mo ago
Transforming Medical Data into Reasoning Traces for Improved LLM Clinical Performance
The article discusses how the value of data has shifted in the age of LLMs, arguing that simply having proprietary data is no longer suffici
galsapir.github.io·4mo ago
Why patients should be cautious about AI scribing systems in medical appointments
Emily M. Bender and Decca Muldowney argue against the use of AI-powered automatic scribing systems in healthcare settings. The article detai
buttondown.com·1mo ago
Why Current AI Agent Benchmarks Are Unreliable and Misleading
The article argues that current AI agent benchmarks are fundamentally flawed and unreliable. Unlike traditional AI benchmarks, agent benchma
ddkang.substack.com·11mo ago